Status:
RECRUITING
LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes
Lead Sponsor:
Copernicus Memorial Hospital
Collaborating Sponsors:
Medical Research Agency, Poland
Conditions:
Lymph Node Neoplasm
Lymph Node Metastasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The project aims to evaluate the value of the new LN-RADS scales for lymph node classification in CT and MR and to compare this method with two other methods RECIST 1.1 and Node-RADS. The main tested...
Eligibility Criteria
Inclusion
- diagnosed or suspected cancer,
- planned lymph node biopsy or lymphadenectomy,
- planned or performed CT/MRI covering an area of the body with lymph nodes, - verified histopathologically or cytologically,
- informed consent to participate in the study.
Exclusion
- non-diagnostic CT/MRI images of lymph nodes due to reasons such as movement artifacts, artifacts from metal elements and any other factors that do not allow for proper assessment of the nodes,
- inconclusive histopathological or cytological results, which do not allow the nodes to be classified into one of two groups - benign or malignant.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06527027
Start Date
December 1 2023
End Date
December 31 2028
Last Update
December 30 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria Skłodowska-Curie National Research Institute of Oncology - National Research Institute
Krakow, Poland
2
Copernicus Memorial Hospital
Lodz, Poland, 93-513
3
Independent Public Healthcare Centre (SPZOZ) , University Clinical Hospital No. 2 of the Medical University of Łódź
Lodz, Poland
4
Doradztwo i Zarządzanie w Opiece Zdrowotnej A.K. Sp.z o.o
Warsaw, Poland